Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01707498
Other study ID # 2012-A00613-40
Secondary ID
Status Recruiting
Phase N/A
First received October 5, 2012
Last updated January 31, 2018
Start date February 2013
Est. completion date January 2018

Study information

Verified date January 2018
Source Centre d'Investigation Clinique et Technologique 805
Contact DAVID ORLIKOWSKI, MD PHD
Email david.orlikowski@rpc.aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is multi-center prospective randomized trial evaluating the effectiveness of a new brain-computer interface for communication of quadriplegic patients in a clinical context. This performance of this will compared to traditional assistive technology (scanning system) and to performance of a healthy volunteer population.


Description:

The evaluation aims to estimate the performance of BCIs in patient and healthy subjects in a clinical setting (primary objective) and to compare this performance with an existing assitive technology adapted to the target population of this study (scanning system). A quadriplegic patient population (n = 10) evaluated the two techniques and a population of healthy subjects (n = 10) evaluated the BCI only.

When a subject meets all the eligibility criteria and is not discarded by any non-inclusion criteria, he is included in the study. The order of the two techniques to be compared is randomized.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Healthy volunteers:

- Informed consent

- Adults aged more than 18yo

- Passed complete medical check-up (heart-rate, blood pressure,...)

- Negative pregnancy test

Quadripleagic patients:

- Informed consent

- Adults aged more than 18years

- Passed medical exam

- Negative pregnancy test

- Full medical checkup

- haemodynamic stability

Exclusion Criteria:

Healthy volunteers:

- history of epilepsy or seizure

- auditory or visual deficit

- atopic scalp dermatitis

- hypersensitivity to gold

- curator/guardianship/under protection of judicial authority

- unable to understand the information note and/or to cooperate

- no social security

- can't read

Quadripleagic patients:

- history of epilepsy or seizure

- auditory or visual deficit

- cerebral lesion

- atopic scalp dermatitis

- hypersensitivity to gold

- curator/guardianship/under protection of judicial authority

- unable to understand the information note and/or to cooperate

- no social security

- can't read

- included in a different clinical trial with exclusion period

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Scanning device
Patients will be asked to spell a text with a specific scanning device. The most appropriate contactor or clicking device will be chosen by a senior therapist.
RoBIK Brain-Computer Interface
Patients will be asked to spell a text with the BCI

Locations

Country Name City State
France Hopital Raymond Poincare Garches

Sponsors (2)

Lead Sponsor Collaborator
Centre d'Investigation Clinique et Technologique 805 University of Versailles

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary BIT RATE IN BIT PER MINUTE(bpm) Bitrate (bpm): transfer of information from patient to computer in bits per minutes. This is a reference measurement to compare P300 speller Brain Computer Interfaces. It uses: number of choices on the interface (N), the average time to select one key (t) and the error rate (e) 15 MINUTES
Secondary Installation time (seconds) Installation time (seconds), Number of caracters spelt in a pre-defined time, Error rate: Area Under the Receiver Operating Curve (AUROC), Balanced Error Rate (BER), Visual Analogous Scale for tiredness (before, after the use) and overall satisfaction. 60 mns
See also
  Status Clinical Trial Phase
Completed NCT05095454 - Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With SCI N/A
Completed NCT01896037 - Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Phase 4